Archive for January 2024

Biogen is officially pivoting away from Aduhelm, the first Alzheimer’s treatment the Cambridge drugmaker made. Biogen said over the past year it looked for potential partners or external financing for Aduhelm, but neither materialized. Read More

Faneuil Hall Marketplace vendors reacted on Tuesday with excitement at the news that a new property operator will soon take over the tourist mecca. Read More

Following the collapse of Amazon’s plan to acquire iRobot Corp. earlier this week, it’s uncertain what the future of the company behind the Roomba will look like. Here’s a timeline of iRobot’s more than three decades as a Bay State tech company. Read More

WNDR Museum describes itself as being at the intersection of art and technology. It’s coming to Boston for the first time. Read More

The Boston Business Journal has announced the special-category honorees for its 2024 Middle Market Leaders awards: innovator of the year, deal of the year and Keybank executive of the year. Read More

Senzime, a Swedish medical device company that develops patient monitoring systems, this month moved its U.S. headquarters to St. Louis. The CEO said the move was influenced by the high cost of doing business in Boston. Read More

About six months after Avrobio Inc. said it was looking into selling itself, the Cambridge biotech has landed a deal. Read More

Nurses at St. Vincent Hospital have filed complaints with federal and state agencies, claiming that conditions at the Worcester hospital have gotten so dangerous that the safety of patients is threatened. Read More

The transaction is an early example of what landlords and bankers expect to begin seeing more often in Boston: the sale of office properties that have been turned over to a lender after a dramatic drop-off in value. Read More

The startup incubator is set to open in a few months, and will be the first of its kind in Maine. Read More